583P Baseline plasma tumour DNA (ptDNA) correlates with PSA kinetics in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide.
Saved in:
| Title: | 583P Baseline plasma tumour DNA (ptDNA) correlates with PSA kinetics in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide. |
|---|---|
| Authors: | Conteduca, V.1 (AUTHOR), Scarpi, E.1 (AUTHOR), Wetterskog, D.2 (AUTHOR), Brighi, N.1 (AUTHOR), Schepisi, G.3 (AUTHOR), Romanel, A.4 (AUTHOR), Casadei, C.1 (AUTHOR), Lolli, C.3 (AUTHOR), Gurioli, G.1 (AUTHOR), Toma, I.5 (AUTHOR), Poti, G.6 (AUTHOR), Farolfi, A.3 (AUTHOR), Demichelis, F.4 (AUTHOR), Attard, G.2 (AUTHOR), De Giorgi, U.1 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS633-S633. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.08.1096 |
